Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
Mai EK, Huhn S, Miah K, Poos AM, Scheid C, Weisel KC, Bertsch U, Munder M, Berlanga O, Hose D, Seckinger A, Jauch A, Blau IW, Hänel M, Salwender HJ, Benner A, Raab MS, Goldschmidt H, Weinhold N.
Mai EK, et al. Among authors: hanel m.
Blood Cancer J. 2023 Jan 4;13(1):1. doi: 10.1038/s41408-022-00772-9.
Blood Cancer J. 2023.
PMID: 36599831
Free PMC article.
Clinical Trial.